ArticleCancer science2021

Pyruvate dehydrogenase kinase 4-mediated metabolic reprogramming is involved in rituximab resistance in diffuse large B-cell lymphoma by affecting the expression of MS4A1/CD20.

Duanfeng Jiang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.